Women's Health Innovation Summit, Europe 2023

Women's Health Innovation Summit

Showcasing innovation, fuelling investment, and driving partnerships across Europe and Israel to improve the outcomes, access, and quality of healthcare for women.

Download the agenda
Basel, Switzerland
26-27 April, 2023

Our agenda is now live! View your copy and discover our 2023 sessions and speakers.

Why Attend

Building on the success of the Women’s Health Innovation Summit Europe 2022, we are returning to Switzerland to drive our mission of improving the access to and quality of healthcare for women across the globe. 

Whilst the distribution of FemTech companies in Europe currently sits at 27% (in comparison to North America’s 51%), there is the potential for huge growth in the market. Our event aims to act as the catalyst for this growth in the development of solutions in this underserved area. 

Our summit will offer the opportunity for connection and partnership, bringing together the leaders and innovators from Europe and Israel, from large pharmaceutical companies and biotechs to start-ups, investors, and service providers, to collectively drive forward the women’s health market. 

Join us in Basel to help drive this change through sparking innovation, sharing research and forging essential partnerships. 

Advisory Board

Author:

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

Author:

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio.

Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.

Outside of work Jess can be found enjoying London’s restaurants, cycling, running, trying out the newest fitness class on offer, or in the park running around with / after her dog.

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio.

Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.

Outside of work Jess can be found enjoying London’s restaurants, cycling, running, trying out the newest fitness class on offer, or in the park running around with / after her dog.

Author:

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

Author:

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Author:

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Author:

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

Author:

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

Author:

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables

2023 Innovation Showcase

Our Innovation Showcase at the first Women’s Health Innovation Summit Europe saw a group of start-ups from across the women’s health industry take to the stage to highlight their technology, device, service, or product that is driving the future of care.

This year, 15 start-up companies, selected by our expanded Selection Committee, will present in front of our audience of over 350 potential partners and investors for the chance to win our brand-new prize bundle, as well as gain exposure and be placed at the forefront of driving solutions in the industry.

All applications are stage agnostic and can relate to all solutions across women’s health.

Prize bundle includes:

• VIP Pass + Guest Ticket to a Future WHIS Event
• 30 Minute Online Coaching Session from FemTech France
• Coaching Session from FemTech Lab

More prizes to be announced soon.

Applications close Friday 10th March.

INNOVATION SHOWCASE & CEO & FOUNDERS FORUM

CEO & Founders Forum

Come together with like-minded leaders in women’s health to learn, network, and grow. 

The CEO & Founders Forum is an application-only event and we will inform you if you are accepted to join.

CEO & FOUNDERS FORUM-ONLY APPLICATION

Selection Committee

Author:

Chantal Cox

Early Stage Investor
Octopus Ventures

Chantal Cox

Early Stage Investor
Octopus Ventures

Author:

Cynthia Jurytko

Venture Partner
Lucy Capital

Cynthia Jurytko

Venture Partner
Lucy Capital

Author:

Erica van Eeghen

Investment Manager
Borski Fund

Erica van Eeghen

Investment Manager
Borski Fund

Author:

Fiona Pathiraja

Managing Partner
Crista Galli Ventures

Fiona Pathiraja

Managing Partner
Crista Galli Ventures

Author:

Hana Besbes

Investment Manager
Heal Capital

Hana is Investment Manager with Heal Capital, a European VC with a volume of EUR 100m, investing in technology-enabled healthcare champions actively driving healthcare innovation from Seed and Series A stage. At Heal, Hana is driving investments in the areas of Mental Health, FemTech, Elderly Care, and Chronic Diseases. Hana has been an active Angel Investor, invested in 30+ startups, and is an advocate of female founders in tech. Hana is a former top-tier strategy consultant with BCG and Roland Berger with > 6 years across Europe and MENA in digital transformation / open innovation and building new industries from scratch. Hana has a technical background as Dipl.-Ing. Electrical Engineering, MSc Telecommunications.

Hana Besbes

Investment Manager
Heal Capital

Hana is Investment Manager with Heal Capital, a European VC with a volume of EUR 100m, investing in technology-enabled healthcare champions actively driving healthcare innovation from Seed and Series A stage. At Heal, Hana is driving investments in the areas of Mental Health, FemTech, Elderly Care, and Chronic Diseases. Hana has been an active Angel Investor, invested in 30+ startups, and is an advocate of female founders in tech. Hana is a former top-tier strategy consultant with BCG and Roland Berger with > 6 years across Europe and MENA in digital transformation / open innovation and building new industries from scratch. Hana has a technical background as Dipl.-Ing. Electrical Engineering, MSc Telecommunications.

Author:

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus is passionate about helping others – especially founders – and will assist in every aspect of building your company. Investors and founders trust him, his hands-on approach and his knowledge around numbers. With more than 35 investments, he and the Calm/Storm team have demonstrated the ability to find and pick those rare cases where entrepreneurs are able to build both outstanding products and big businesses. Lucanus also has a real passion for digital solutions that improve our lives, and has most likely hit the limit of the number of apps "installable" on a phone.

In his free time, you’ll find him spending time with his wife and three children in the most liveable city in the world, Vienna, Austria, or sometimes racing sailing boats in his home turf, Lake Attersee in beautiful Salzkammergut – or as he calls it, “The Sound Of Music Land”.

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus is passionate about helping others – especially founders – and will assist in every aspect of building your company. Investors and founders trust him, his hands-on approach and his knowledge around numbers. With more than 35 investments, he and the Calm/Storm team have demonstrated the ability to find and pick those rare cases where entrepreneurs are able to build both outstanding products and big businesses. Lucanus also has a real passion for digital solutions that improve our lives, and has most likely hit the limit of the number of apps "installable" on a phone.

In his free time, you’ll find him spending time with his wife and three children in the most liveable city in the world, Vienna, Austria, or sometimes racing sailing boats in his home turf, Lake Attersee in beautiful Salzkammergut – or as he calls it, “The Sound Of Music Land”.

Author:

Nathan McNally

Partner
Goddess Gaia Ventures

Nathan McNally

Partner
Goddess Gaia Ventures

Author:

Samira Ann Qassim

Co-Founder
Pink Salt Ventures

Samira Ann Qassim

Co-Founder
Pink Salt Ventures

Author:

Triin Linamagi

Founding Partner
Sie Ventures

Triin Linamagi

Founding Partner
Sie Ventures

Author:

Vijay Barathan

Partner
Optum Ventures

Vijay Barathan

Partner
Optum Ventures

Author:

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009. Wendy chairs the Board at Be Girl, a mission-driven design company addressing menstruation, is on the Executive Board of Women Moving Millions and sits on the advisory boards of both Saral Designs and The Center for Intimacy Justice.

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009. Wendy chairs the Board at Be Girl, a mission-driven design company addressing menstruation, is on the Executive Board of Women Moving Millions and sits on the advisory boards of both Saral Designs and The Center for Intimacy Justice.

Author:

Yahel Halamish

Principal
Nina Capital

Yahel joined Nina Capital, a specialized venture capital firm investing exclusively at the intersection of healthcare and deep tech, in 2020. At Nina Capital, Yahel focuses on Women's health and hospital management investments. She is also in charge of Investors Relations and D&I in the fund, promoting an active approach to increasing diversity. Prior to joining Nina Capital, Yahel gained vast knowledge on the VC industry and Startups in different development stages by investing in Alternative Assets for a large investment house based in Tel Aviv. Yahel started her career as a corporate lawyer, working for a top law firm in Israel, managing ongoing legal matters of public companies and IPOs. Yahel holds an MBA from IESE Business School, LLB and, BA in economics from the Hebrew University.

Yahel Halamish

Principal
Nina Capital

Yahel joined Nina Capital, a specialized venture capital firm investing exclusively at the intersection of healthcare and deep tech, in 2020. At Nina Capital, Yahel focuses on Women's health and hospital management investments. She is also in charge of Investors Relations and D&I in the fund, promoting an active approach to increasing diversity. Prior to joining Nina Capital, Yahel gained vast knowledge on the VC industry and Startups in different development stages by investing in Alternative Assets for a large investment house based in Tel Aviv. Yahel started her career as a corporate lawyer, working for a top law firm in Israel, managing ongoing legal matters of public companies and IPOs. Yahel holds an MBA from IESE Business School, LLB and, BA in economics from the Hebrew University.

INVESTOR FORUM

New to WHIS EU, the Investor Forum will offer further networking and discussion for investors in the women’s health space who share the same passion for driving change and accelerating innovation.

We’re delighted to announce that Jessica McCreadie, Principal at Octopus Ventures will host this year’s forum, bringing her extensive expertise and knowledge. 

Register your interest in the forum and a team member will be in touch with further information.

REGISTER INTEREST

Key statistics

350+
Attendees
40+
Speakers
15+
Dedicated Networking Hours
100+
Start-ups

AUDIENCE BREAKDOWN

Start Ups/ Femtech/ Entrepreneurs/ Innovation

We are committed to increasing exposure of emerging companies in women’s health, at all stages of growth and development, who are seeking partnership opportunities and are at the forefront of shaping the future of this space.

Pharma/ Medical Device & Diagnostics/Biotechs

At the forefront of innovation, big pharma, medical device, and biotech companies play a key role in shaping the investments and innovation happening in the women’s health sphere.

Investors/Funding Groups

We look to bring together leading investors with a particular focus in women’s health, ranging from seed, to angel, venture capital firms, private equity, funds, and advisors.

Non-profits/ Advocacy Groups

Non-profit organizations and advocacy groups play a key part in our Summits, and in the women’s health space in general, ensuring the fight towards health equity continues and awareness of the industry is being spread. 

Payors/Employers

Payers, insurance companies, and benefit providers provide an important bridge between stakeholders within the women’s health industry, and we are delighted to have more joining us at this years’ summit.

Service Providers

Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts.

THIS YEAR’S ATTENDEES INCLUDE

2023 Partners

Oncology Partner

PLATINUM PARTNER

Gold Partner

Media Partners

2023 Speakers

 

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables
 

Tania Boler

CEO & Founder
Elvie

Tania Boler

CEO & Founder
Elvie

Tania Boler

CEO & Founder
Elvie
 

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women
 

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

 

Valentina Sartori

Partner
McKinsey & Co

Valentina Sartori

Partner
McKinsey & Co

Valentina Sartori

Partner
McKinsey & Co
 

Chantal Cox

Early Stage Investor
Octopus Ventures

Chantal Cox

Early Stage Investor
Octopus Ventures

Chantal Cox

Early Stage Investor
Octopus Ventures
 

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co.

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co. She has a PhD in chemical engineering from MIT and an MBA from the MIT Sloan.

 

Erini Rapti

CEO & Co-Founder
Inne

Erini Rapti

CEO & Co-Founder
Inne

Erini Rapti

CEO & Co-Founder
Inne
 

Fiona Pathiraja

Managing Partner
Crista Galli Ventures

Fiona Pathiraja

Managing Partner
Crista Galli Ventures

Fiona Pathiraja

Managing Partner
Crista Galli Ventures
 

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova is the founder of Daye, the gynae health research and development company on a mission to close the gender pain gap and overcome historical gender biases in medical research and product innovation. After years of research and testing, Daye launched its first consumer product in 2020 - the world‘s only cramp-soothing tampon.  From the outset, Valentina has baked her core values into the DNA of the company - Daye‘s products are created by women who used to be in the prison system, and their tampons are produced in a fully carbon neutral operation.

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova is the founder of Daye, the gynae health research and development company on a mission to close the gender pain gap and overcome historical gender biases in medical research and product innovation. After years of research and testing, Daye launched its first consumer product in 2020 - the world‘s only cramp-soothing tampon.  From the outset, Valentina has baked her core values into the DNA of the company - Daye‘s products are created by women who used to be in the prison system, and their tampons are produced in a fully carbon neutral operation. Born and raised in Bulgaria, Valentina moved to the UK to attend the University of Buckingham, where she got degrees in business, economics, and law.  After considering careers in journalism and econometrics, Valentina soon found herself drawn in by the start-up world, working first at Techstars and then as a venture associate for Founders Factory. Meanwhile, she began working on her own idea for a company. After 180 pitches to investors, Valentina managed to raise £4.23 million in seed funding and in 2018, Daye started officially changing the face of female health for the better.

 

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009.

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson

Partner & Co-Founder
The Case For Her

Wendy Anderson is a Co-founder and Investing Partner at The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and female sexual health & pleasure. A graduate of Queen’s University in Ontario, Canada, Wendy spent over a decade working in the financial industry before transitioning to impact investing at Futura Foundations, which she directs together with her husband, acting as Chair of Social Initiatives since 2009. Wendy chairs the Board at Be Girl, a mission-driven design company addressing menstruation, is on the Executive Board of Women Moving Millions and sits on the advisory boards of both Saral Designs and The Center for Intimacy Justice.

 

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude
 

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson
 

Jérôme Michaud

Business Partner
Innopearl

Jérôme Michaud

Business Partner
Innopearl

Jérôme Michaud

Business Partner
Innopearl
 

Cristina Bescos

Director of Innovation
EIT Health

Cristina Bescos

Director of Innovation
EIT Health

Cristina Bescos

Director of Innovation
EIT Health
 

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus Polagnoli

Founder & Managing Director
CalmStorm Ventures

Lucanus is one of Europe’s emerging managers: He is a founder and managing partner at Calm/Storm, an early-stage venture capital fund focused on digital-health and wellbeing. Before founding Calm/Storm in 2020, he was a startup operator, a CFO and a general partner of an early-stage fund (Speedinvest) – a combination not often found in venture capital.

Lucanus is passionate about helping others – especially founders – and will assist in every aspect of building your company. Investors and founders trust him, his hands-on approach and his knowledge around numbers. With more than 35 investments, he and the Calm/Storm team have demonstrated the ability to find and pick those rare cases where entrepreneurs are able to build both outstanding products and big businesses. Lucanus also has a real passion for digital solutions that improve our lives, and has most likely hit the limit of the number of apps "installable" on a phone.

In his free time, you’ll find him spending time with his wife and three children in the most liveable city in the world, Vienna, Austria, or sometimes racing sailing boats in his home turf, Lake Attersee in beautiful Salzkammergut – or as he calls it, “The Sound Of Music Land”.

 

Stephanie Kuku

MD, Advisor
Hardian Health

Stephanie Kuku

MD, Advisor
Hardian Health

Stephanie Kuku

MD, Advisor
Hardian Health
 

Mathieu Horras

CEO & Founder
Aspivix

Mathieu Horras

CEO & Founder
Aspivix

Mathieu Horras

CEO & Founder
Aspivix
 

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany.

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Maria Liechtenstein

Investor Director
M Ventures

Therese Liechtenstein, PhD, is a Principal in the Biotechnology team of M Ventures. Therese joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Therese managed strategic projects for the Healthcare business of Merck KGaA in Darmstadt, Germany. Prior to Merck KGaA, Darmstadt, Germany, Therese was a client relationship manager in the field of wealth preservation, at Industrie- & Finanzkontor Ets. Therese comes from an academic background receiving her PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.

 

Yotam Hod

CEO & Co-Founder
Gynica

Yotam Hod

CEO & Co-Founder
Gynica

Yotam Hod

CEO & Co-Founder
Gynica
 

Ipek Gunduz

Co-Founder & Partner
Bold Innovates

Ipek Gunduz

Co-Founder & Partner
Bold Innovates

Ipek Gunduz

Co-Founder & Partner
Bold Innovates
 

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates
 

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster
 

Maeve Cusack

Board Member
EIWH

Maeve Cusack

Board Member
EIWH

Maeve Cusack

Board Member
EIWH
 

Wei Escala

Founder & CEO
Eggschain

Wei Escala

Founder & CEO
Eggschain

Wei Escala

Founder & CEO
Eggschain
 

Kenneth Drury

Chief Scientific Officer
Eggschain

Kenneth Drury

Chief Scientific Officer
Eggschain

Kenneth Drury

Chief Scientific Officer
Eggschain
 

Cecile Real

CEO & Co-Founder
Endodiag

Cecile Real

CEO & Co-Founder
Endodiag

Cecile Real

CEO & Co-Founder
Endodiag
 

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F
 

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks

View the 2023 agenda

Our 2023 agenda is now available to view. Sessions include:

  • The European Women's Health Landscape
  • Overcoming and Understanding European Regulatory Challenges
  • 30 Years of Women in Clinical Trials: Where are we Now?
  • Blockchain in the Assisted Reproductive Technology Industry: Challenges and Opportunities
  • Technology and Community as Tools for Education
  • Endometriosis: Going Beyond Diagnosis

View the 2023 #WHISEU Agenda

RESOURCES

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, October 1, 2022 to Thursday, April 27, 2023
Academic/NPO/Charity Rate
€599
Tuesday, November 15, 2022 to Friday, January 6, 2023
Emerging - Under 5mil Rev
€ 599
Super Early Bird (Register before the 06 Jan and save €300)
Tuesday, November 15, 2022 to Friday, January 6, 2023
Emerging - Under 10mil Rev
€ 799
Super Early Bird (Register before the 14th Nov and save €300)
Tuesday, November 15, 2022 to Friday, January 6, 2023
Industry
€ 1,499
Super Early Bird (Register before the 06 Jan and save €600)
Tuesday, November 15, 2022 to Friday, January 6, 2023
Service Providers
€1,999
Super Early Bird (Register before the 06 Jan and save €600)
Preparing registration...

Venue Description

Venue

Congress Center Basel Messepl. 21, 4058 Basel, Switzerland

The Congress Center Basel is the largest congress center in Switzerland in terms of area. Look forward to comfortable furnishings and the latest technology that meets even the highest demands.

Partner With Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

DOWNLOAD SPEX PROSPECTUS

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Other events you might be interested in:

Women's Health Innovation Series: Women's Healthy Aging Summit

Women's Health Innovation Summit 2023

Reproductive Health Innovation Summit